#AI is transforming antibiotic discovery. But will the persistent lack of private investment into antibiotics hinder the ability to advance promising AI-discovered candidates into the clinic and toward patients in need? #AMR via @BulletinAtomic.

RT @LeapsByBayer: Antibiotic-resistant infections are the 2nd leading cause of death in cancer patients. We need policy reform and incentiv….

Shionogi and BioVersys strike deal to advance new treatments for nontuberculous mycobacterial infections

"Investors will continue to avoid antibiotics until policymakers enact meaningful policies that incentivise investment into antibiotic R&D. " #AMR Action Fund's Henry Skinner said

"Antimicrobial resistance disproportionately impacts patients with cancer, because many have weakened immune systems that make them completely reliant on effective antibiotics." @Forbes examines how #AMR is undermining #cancer care and harming patients

Want to know the the state of play in Europe for pull incentives? Our international policy director assesses the landscape in this new Q&A with @JohnRex_NewAbx #AMR #EU #policy.

The "crisis of AMR is a crisis of cancer care delivery.” Very powerful @Forbes article examining how #AMR is undermining advances in #cancer care and harming patients.

A new paper modeled the impact that various climate change scenarios could have on fungal pathogens and patients in Europe. Under one scenario, Aspergillus fumigatus could increase by 77.5% and potentially expose 9 million people in Europe #AMR.

Interested in #cancer and #AMR? Then sign up for @uicc's upcoming (and free) webinar exploring ways to improve data collection and surveillance to understand these overlapping challenges. Register here:

If you are at #BIO2025, don’t miss today’s session on how #AMR is undermining an array of medical advances, from breakthrough cancer treatments to surgical procedures and transplants.

RT @WeFightAMR: From cancer to organ transplants, AMR threatens to derail progress in medicine. Today, the @AMRActionFund leads a breakout….

Artificial intelligence may be the tool humanity needs to turn the tables on #AMR. But will unfavorable market conditions and lack of R&D investment limit the ability of researchers to advance #AI-driven discoveries into the clinic and toward patients?

Lot of concern being expressed on #BIO25 #AMR panel over “brain drain” and its impact on antimicrobial R&D. Read more on this issue via @statnews op-ed by Henry Skinner

Exciting week on deck with @IAmBiotech in town. Say 👋 if you’re in Boston.

Interesting study out of @RutgersU showing that ciprofloxacin can throw E. coli into an energy crisis that saves many cells from death and speeds the evolution of full-blown resistance. #AMR

"This increased resistance poses a major clinical challenge in the outpatient setting, where therapeutic options are often limited to oral therapies,” the researchers wrote," #AMR #Cancer via @ONAcom

Each major hurricane that has made landfall in recent years has had infectious fallout, from outbreaks of flesh-eating bacteria in Florida to E. coli-contaminated drinking water in North Carolina and elsewhere. Learn more via @PublicHealthMag #AMR

The fungal crisis is here and desperately needs addressing: A quick assessment of the armamentarium of antifungal agents shows just how underprepared countries are. fungal infections receive less than 1.5% of all infectious disease research funding #AMR.

RT @WeFightAMR: Antibiotic development has slowed, leaving us vulnerable to superbugs. AI is shifting that trajectory by accelerating the s….

"These infections are a daily reality across all age groups. We often see patients for whom no antibiotic works - and they die," @draghafur tells @BBCNews #AMR.